Lippincott's Review of Pathology: Illustrated Interactive Q & a
Description:
Featuring over 1,100 multiple-choice, clinical vignette-style questions, this Q&A book provides the most up-to-date, clinically relevant review of pathology. It helps medical students master the vast amount of pathology information they need to succeed on the USMLE, and serves as an excellent review tool for students in other health professions.
Using the format of the National Board of Medical Examiners, the questions address the general and systemic pathology topics detailed in the highly-acclaimed textbook Rubin's Pathology: Clinicopathologic Foundations of Medicine. Correct and incorrect answers are explained in detailed rationales linked to clinical vignettes. Over 300 full-color images link clinical and pathologic findings.
To give students practice for the computer-generated USMLE, the questions are also available online on our Connection Website.
Best prices to buy, sell, or rent ISBN 9780781795807
Frequently Asked Questions about Lippincott's Review of Pathology: Illustrated Interactive Q & a
The price for the book starts from $6.67 on Amazon and is available from 7 sellers at the moment.
At BookScouter, the prices for the book start at $2.69. Feel free to explore the offers for the book in used or new condition from various booksellers, aggregated on our website.
If you’re interested in selling back the Lippincott's Review of Pathology: Illustrated Interactive Q & a book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Lippincott's Review of Pathology: Illustrated Interactive Q & a book, the best buyback offer comes from and is $ for the book in good condition.
The Lippincott's Review of Pathology: Illustrated Interactive Q & a book is in very low demand now as the rank for the book is 8,766,635 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.